Kamal Dawood

Prof. Kamal Dawood

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2006 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
KDKamal Dawood
Kamal Dawood
Hassan Abdel-GawadHassan Abdel-Gawad
Hassan Abdel-Gawad
EREman A. Rageb
Eman A. Rageb
MEMohey Ellithey
Mohey Ellithey
HMHanan A. Mohamed
Hanan A. Mohamed

17 May 2013 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
KDKamal Dawood
Kamal Dawood
Introduction: Benzofuran moiety constitutes the core of several interesting pharmacologically active natural products. Benzofurans are among feasible potent active inhibitors against many diseases, viruses, microbes, fungus and enzymes. Several series of therapeutically important synthetic and naturally occurring benzofuran-containing compounds are reported in this chapter. Areas covered: The current chapter focuses on the recent applications of benzofuran scaffolds and their wide range of biological activities during 1999 – 2012. The pharmacological areas covered included anti-inflammatory, antitumor, cytotoxic, antimicrobial, antitubercular, antioxidant, antiplasmodial, trypanocidal and insecticidal activities as well as enzyme inhibitory, HCV and HIV inhibitory activities. Expert opinion: The results reported in the chapter indicate that some benzofuran derivatives may be useful as potent drugs. From the structure–activity relationship (SAR), the presence of certain functions like -OH, -OMe in the benzofuran derivatives contributed greatly in increasing the potency of their therapeutic activities when compared with standards. For example, presence of the -OH and -OMe have made some benzofuran compounds more potent HIV-RT inhibitory activity than the standard atevirdine, and more potent antitumor agent when compared with standards (fluorouracil, doxorubicin and cytarabine). In addition, the enzyme aromatase CYP19 inhibitory activity of benzofurans having -OH and -OMe were greater than that observed for the reference arimidex.

1 December 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KDKamal Dawood
Kamal Dawood
TETaha M.A. Eldebss
Taha M.A. Eldebss
HEHeba S.A. El-Zahabi
Heba S.A. El-Zahabi
MYMahmoud H. Yousef
Mahmoud H. Yousef
PMPeter Metz
Peter Metz

1 September 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KDKamal Dawood
Kamal Dawood
TETaha M.A. Eldebss
Taha M.A. Eldebss
HEHeba S.A. El-Zahabi
Heba S.A. El-Zahabi
MYMahmoud H. Yousef
Mahmoud H. Yousef

10 March 2006 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
KDKamal Dawood
Kamal Dawood
Hassan Abdel-GawadHassan Abdel-Gawad
Hassan Abdel-Gawad
MEMohey Ellithey
Mohey Ellithey
HMHanan A. Mohamed
Hanan A. Mohamed
BHBahira Hegazi
Bahira Hegazi

3 April 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
AAAshaf Abbas
Ashaf Abbas
KDKamal Dawood
Kamal Dawood
Benzofuran moiety is the main component of many biologically active natural and synthetic heterocycles.